about
Selective androgen receptor modulators in preclinical and clinical developmentMultiple hormonal deficiencies in anabolic hormones are found in frail older women: the Women's Health and Aging studiesHuman Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining ConditionsSex differences in the association between serum levels of testosterone and frailty in an elderly population: the Toledo Study for Healthy AgingOff-label use of hormones as an antiaging strategy: a reviewFrailty, serum androgens, and the CAG repeat polymorphism: results from the Massachusetts Male Aging Study.Drug discovery and development for ageing: opportunities and challenges.Serum sex steroid hormones and frailty in older American men of the Third National Health and Nutrition Examination Survey (NHANES III)Testosterone level and the effect of levodopa and agonists in early Parkinson disease: results from the INSPECT cohortIndications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators.Predictors of serum testosterone and DHEAS in African-American men.The analysis of the transcriptome as a new approach for biomarker development to trace the abuse of anabolic steroid hormones.The frailty syndrome: a comprehensive review.Frailty and Primary Sarcopenia: A Review.Physical frailty predicts future cognitive decline - a four-year prospective study in 2737 cognitively normal older adults.Low FT3: a possible marker of frailty in the elderly.Frailty: an emerging concept for general practice.
P2860
Q24645579-B1DB13CB-B259-4383-959D-6C04386B9B4DQ24658164-3EB2DE4B-F2F1-456B-AFC1-01E3D98BE618Q26740117-3F2B6434-5AD0-48CB-BB06-59DF5FB1604EQ28731543-D389C625-99B3-4FED-97A5-8E6B6D3983EBQ33976165-05F4B07D-4566-4159-A103-B65003B85563Q33984883-845242E7-7A3A-4417-B373-DE2F79CD7AE5Q34402737-8B022D6C-A98D-42D6-A27F-73A1A12632DEQ36089176-CB083A33-99B2-4B00-8407-89CFDCD321A4Q36457430-DA35F459-96B3-4ECC-B223-332F7104E9F2Q37132149-F094A0A9-A561-475A-B05D-C09ADDD41DC2Q37280315-C05B8314-EAD5-4065-9882-3B62BE94364CQ37928626-E60D9AFF-1431-4B24-B118-B4331A645DC4Q37958026-42936D59-1CE1-4754-AE72-62D61CDA97CEQ39223707-C0AC4AE3-60E9-4B43-B749-BB4BED0C0E12Q39701295-5D5F29FA-745A-44B0-9611-F9F425435E9CQ41770426-D41DB7E4-C6A5-4A76-A513-731D052204F6Q43141370-C8CE3EC3-9441-4519-9EEF-A851DFC13F5B
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Frailty and hormones.
@ast
Frailty and hormones.
@en
type
label
Frailty and hormones.
@ast
Frailty and hormones.
@en
prefLabel
Frailty and hormones.
@ast
Frailty and hormones.
@en
P2093
P2860
P1476
Frailty and hormones.
@en
P2093
John E Morley
Matthew T Haren
Moon Jong Kim
P2860
P2888
P304
P356
10.1007/S11154-005-6722-9
P577
2005-05-01T00:00:00Z